Levamisole-induced leukocytoclastic vasculitis and neutropenia in a patient with cocaine use: An extensive case with necrosis of skin, soft tissue, and cartilage

Addiction Science and Clinical Practice

Volumn 7, Issue 1, 2012, Pages

  Arora, Natasha Purai ^a   Jain, Tania ^a   Bhanot, Ravinder ^a   Natesan, Suganthini Krishnan ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cutaneous vasculitis; Leukocytoclastic vasculitis; Levamisole; Retiform purpura

Indexed keywords

ANTINEMATODAL AGENT; LEVAMISOLE;

ADULT; ARTICLE; CARTILAGE; CASE REPORT; CHEMICALLY INDUCED DISORDER; COCAINE DEPENDENCE; FEMALE; HUMAN; LEUKOCYTOCLASTIC VASCULITIS; NECROSIS; NEUTROPENIA; SKIN;

ADULT; ANTINEMATODAL AGENTS; CARTILAGE; COCAINE-RELATED DISORDERS; FEMALE; HUMANS; LEVAMISOLE; NECROSIS; NEUTROPENIA; SKIN; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS;

EID: 84873714698     PISSN: 19400632     EISSN: 19400640     Source Type: Journal    
DOI: 10.1186/1940-0640-7-19     Document Type: Article

References (37)

1. Buchanan JA, Heard K, Burbach C, Wilson ML, Dart R: Prevalence of levamisole in urine toxicology screens positive for cocaine in an inner-city hospital. JAMA. 2011, 305 (16): 1657-1658. 10.1001/jama.2011.531.
2. Centers for Disease Control and Prevention (CDC): Agranulocytosis associated with cocaine use - four States, March 2008-November 2009. MMWR Morb Mortal Wkly Rep. 2009, 58: 1381-1385.
3. Gross RL, Brucker J, Bahce-Altuntas A, Abadi MA, Lipoff J, Kotlyar D, Barland P, Putterman C: A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine. Clin Rheumatol. 2011, 30 (10): 1385-1392. 10.1007/s10067-011-1805-3.
4. Ullrich K, Koval R, Koval E, Bapoje S, Hirsh JM: Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine. J Clin Rheumatol. 2011, 17 (4): 193-196.
5. Amery WK, Bruynseels JP: Levamisole, the story and the lessons. Int J Immunopharmacol. 1992, 14 (3): 481-486. 10.1016/0192-0561(92)90179-O.
6. Macfarlane DG, Bacon PA: Levamisole-induced vasculitis due to circulating immune complexes. Br Med J. 1978, 1 (6110): 407-408. 10.1136/bmj.1.6110.407.
7. Bradford M, Rosenberg B, Moreno J, Dumyati G: Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann Intern Med. 2010, 152 (11): 758-759.
8. Buchanan JA, Vogel JA, Eberhardt AM: Levamisole-induced occlusive necrotizing vasculitis of the ears after use of cocaine contaminated with levamisole. J Med Toxicol. 2011, 7 (1): 83-84. 10.1007/s13181-010-0097-3.
9. Walsh NMG, Green PJ, Burlingame RW, Pasternak S, Hanly JG: Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole. J Cutan Pathol. 2010, 37 (12): 1212-1219. 10.1111/j.1600-0560.2010.01613.x.
10. Waller JM, Feramisco JD, Alberta-Wszolek L, McCalmont TH, Fox LP: Cocaine-associated retiform purpura and neutropenia: is levamisole the culprit?. J Am Acad Dermatol. 2010, 63 (3): 530-535. 10.1016/j.jaad.2010.01.055.
11. Farhat EK, Moorhead TT, Chaffing ML, Douglass MC: Levamisole-induced cutaneous necrosis mimicking coagulopathy. Arch Dermatol. 2010, 146 (11): 1320-1321. 10.1001/archdermatol.2010.335.
12. Click J: Levamisole-induced retiform purpura. J Drug Dermatol. 2011, 10 (2): 217-
13. Geller L, Whang TB, Mercer SE, Phelps R: Retiform purpura: a new stigmata of illicit drug use?. Dermatol Online J. 2011, 17 (2): 7.
14. Han C, Sreenivasan G, Dutz JP: Reversible retiform purpura: a sign of cocaine use. CMAJ. 2011, 183 (9): 597-600. 10.1503/cmaj.101005.
15. Ching JA, Smith DJ: Levamisole-induced necrosis of skin, soft tissue, and bone: case report and review of literature. J Burn Care Res. 2012, 33 (1): 1-5. 10.1097/BCR.0b013e31823347f6.
16. Mouzakis J, Somboonwit C, Lakshmi S, Rumbak M, Sinnott J, Cherpelis B, Keshishian J: Levamisole-induced necrosis of the skin and neutropenia following intranasal cocaine use: a newly recognized syndrome. J Drugs Dermatol. 2011, 10 (10): 1204-1207.
17. Jacob RS, Silva CY, Powers JG, Schieke SM, Mendese G, Burlingame RW, Miller DD, Wolpowitz D, Graber E, Mahalingam M: Levamisole-induced vasculopathy: a report of 2 cases and a novel histopathologic finding. Am J Dermatopathol. 2012, 34 (2): 208-213. 10.1097/DAD.0b013e31821cc0bf.
18. Lung D, Lynch K, Agrawal S, Armenian P, Banh K: Images in emergency medicine, adult female with rash on lower extremities. vasculopathic purpura and neutropenia caused by levamisole-contaminated cocaine. Ann Emerg Med. 2011, 57 (3): 307-311. 10.1016/j.annemergmed.2010.05.009.
19. Zwang NA, Van Wagner LB, Rose S: A case of levamisole-induced systemic vasculitis and cocaine-induced midline destructive lesion: a case report. J Clin Rheumatol. 2011, 17 (4): 197-200.
20. Chung C, Tumeh PC, Birnbaum R, Tan BH, Sharp L, McCoy E, Mercurio MG, Craft N: Characteristic purpura of the ears, vasculitis, and neutropenia-a potential public health epidemic associated with levamisole-adulterated cocaine. J Am Acad Dermatol. 2011, 65 (4): 722-725. 10.1016/j.jaad.2010.08.024.
21. Jenkins J, Babu K, Hsu-Hung E, Robinson-Bostom L, Kroumpouzos G: ANCA-positive necrotizing vasculitis and thrombotic vasculopathy induced by levamisole-adulterated cocaine: a distinctive clinicopathologic presentation. J Am Acad Dermatol. 2011, 65 (1): 14-16.
22. John S, Manda S, Hamrock D: Cocaine-induced thrombotic vasculopathy. Am J Med Sci. 2011, 342 (6): 524-526. 10.1097/MAJ.0b013e31822979f1.
23. Parkinson DR, Cano PO, Jerry LM, Capek A, Shibata HR, Mansell PW, Lewis MG, Marquis G: Complications of cancer immunotherapy with levamisole. Lancet. 1977, 1 (8022): 1129-1132.
24. Segal AW, Pugh SF, Levi AJ, Loewi G: Levamisole-induced arthritis in Crohn's disease. Br Med J. 1977, 2 (6086): 555.
25. Laux-End R, Inabenit D, Gerber HA, Bianchetti MG: Vasculitis associated with levamisole and circulating autoantibodies. Arch Dis Child. 1996, 75 (4): 355-356.
26. Chang A, Osterloh J, Thomas J: Levamisole: a dangerous new adulterant. Clin Pharmacol Ther. 2010, 88 (3): 408-411. 10.1038/clpt.2010.156.
27. McKellar Q, Marriner S, Bogan J: Comparison of ivermectin, oxfendazole and levamisole for use as anthelmintics during the periparturient period in sheep. Vet Rec. 1988, 122 (23): 558-560. 10.1136/vr.122.23.558.
28. Hembry FG, Miller JE, Sims D, Rodriguez S, Stagg LC: Efficacy of repeated doses of levamisole, morantel, fenbendazole, and ivermectin against gastrointestinal nematodes in ewes. Am J Vet Res. 1986, 47 (8): 1677-1679.
29. Casale JF, Corbeil EM, Hays PA: Identification of levamisole impurities found in illicit cocaine exhibits. Microgram J. 2008, 6 (3,4): 82-89.
30. Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS: Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse. 2001, 39 (1): 32-41. 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3.
31. Howell LL, Kimmel HL: Monoamine transporters and psychostimulant addiction. Biochem Pharmacol. 2008, 75 (1): 196-217. 10.1016/j.bcp.2007.08.003.
32. Martin RJ: Modes of action of anthelmintic drugs. Vet J. 1997, 154 (1): 11-34. 10.1016/S1090-0233(05)80005-X.
33. Raymon LP, Isenschmid DS: Letter to the editor: the possible role of levamisole in illicit cocaine preparations. J Anal Toxicol. 2009, 33 (9): 620-622.
34. Ho EN, Leung DK, Leung GN, Wan TS, Wong AS, Wong CH, Soma LR, Rudy JA, Uboh C, Sams R: Aminorex and rexamino as metabolites of levamisole in the horse. Anal Chim Acta. 2009, 638 (1): 58-68. 10.1016/j.aca.2009.02.033.
35. Shannon M: Clinical toxicity of cocaine adulterants. Ann Emerg Med. 1988, 17 (11): 1243-1247. 10.1016/S0196-0644(88)80078-7.
36. Friedman DR, Wolfsthal SD: Cocaine-induced pseudovasculitis. Mayo Clin Proc. 2005, 80 (5): 671-673. 10.4065/80.5.671.
37. Office of Applied Studies (OAS), Substance Abuse and Mental Health Services Administration (SAMHSA): The. 2005, http://www.oas.samhsa.gov/2k5/cocaine/cocaine.pdf, National Survey on Drug Use and Health Report